Assuming news is required, the following results were found.

  • The IDA Is Championing a Symbol for Invisible Disabilities - Multiple Sclerosis News Today

    other day I read about a woman who tripped, hit her head, and — you guessed it — was accused of being intoxicated. Fellow MS News Today columnist Teresa Wright-Johnson wrote about the problem of invisibility a year ago. I’m sure everyone reading this...

    https://mschristian.org/index.php/articles/2-uncategorised/8951-the-ida-is-championing-a-symbol-for-invisible-disabilities-multiple-sclerosis-news-today
  • #ECTRIMS2019 - Mayzent's Benefits for MS Patients a 'Key Question,' Says EXPAND's Principal Investigator - Multiple Sclerosis News Today

    two years, compared with placebo, in SPMS patients. Ludwig Kappos, principal investigator of the EXPAND study. (Photo by MS News Today) Overall, the data suggest that Mayzent offers a benefit in terms of physical and cognitive ability. But from a...

    https://mschristian.org/index.php/articles/2-uncategorised/8695-ectrims2019-mayzent-s-benefits-for-ms-patients-a-key-question-says-expand-s-principal-investigator-multiple-sclerosis-news-today
  • news.google.com

    https://mschristian.org/index.php/articles/from-the-web/web-rss-feeds/63-ms-articles-from-the-web/12-news-google-com
  • Novartis receives positive CHMP opinion for Mayzent® (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS) | Small Molecules | News Channels - PipelineReview.com

    world. Find out more at www.novartis.com. Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartisnews For Novartis multimedia content, please visit www.novartis.com/news/media-library For questions about the site or required...

    https://mschristian.org/index.php/articles/2-uncategorised/9270-novartis-receives-positive-chmp-opinion-for-mayzent-siponimod-for-the-treatment-of-adult-patients-with-active-secondary-progressive-multiple-sclerosis-spms-small-molecules-news-channels-pipelinereview-com
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    injectable users and nearly 30% of oral therapy initiators had stopped treatment or were considered non-adherent. The good news is that it is possible to change patients’ adherence and persistence, Zakaria said: “You can change it by sharing...

    https://mschristian.org/index.php/articles/2-uncategorised/8956-ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Dori Groenendyk fondly remembered | Sioux Center News - nwestiowa.com

    Dordt College in 1991 and her master’s in education from Covenant College in 2015. “Hearing of her passing was truly hard news to hear,” said Dale Kraayenbrink. He and Groenendyk served on the board together for a couple years before he came off in...

    https://mschristian.org/index.php/articles/2-uncategorised/8950-dori-groenendyk-fondly-remembered-sioux-center-news-nwestiowa-com
  • 9 Resources to Cope with Coronavirus Anxiety

    Share on Pinterest Take a breath and give yourself a pat on the back. You’ve successfully managed to look away from breaking news long enough to find some resources that might actually help with your stress. That’s no easy thing right now. Experts are...

    https://mschristian.org/index.php/blog/9-resources-to-cope-with-coronavirus-anxiety
  • AJMC® in the Press, September 13, 2019 - AJMC.com Managed Markets Network

    Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press. A study published in this month’s issue ofThe American Journal of Managed Care®(AJMC®) evaluated the patterns of clinical service for long-term nursing...

    https://mschristian.org/index.php/blog/ajmc-in-the-press-september-13-2019-ajmc-com-managed-markets-network
  • Havana's 500th Anniversary a missed opportunity to strengthen U.S.-Cuba ties - New York Daily News

    500th Anniversary a missed opportunity to strengthen U.S.-Cuba ties New York Daily News Original link Read More

    https://mschristian.org/index.php/articles/2-uncategorised/9272-havana-s-500th-anniversary-a-missed-opportunity-to-strengthen-u-s-cuba-ties-new-york-daily-news
  • Research Explores Cannabis as Treatment for MS, Alzheimer’s and Huntington’s Disease - Pain News Network

    actually working in people,” Jeffrey Gossain, Atlas’ chief operating officer, told Folio, the University of Alberta's news site. “A lot of people will tell you, 'My mom had cancer’ or, ‘My friend had an illness, and they took cannabis and it helped.’...

    https://mschristian.org/index.php/articles/2-uncategorised/9683-research-explores-cannabis-as-treatment-for-ms-alzheimer-s-and-huntington-s-disease-pain-news-network
  • Mindfulness training shows promise for people with MS

    New research suggests mindfulness training may help multiple sclerosis patients in two very different ways: regulating negative emotions and improving processing speed. People with MS who underwent the four-week mindfulness training not only improved...

    https://mschristian.org/index.php/mindfulness-training-shows-promise-for-people-with-ms
  • Trials and Tribulations: Neurology Research During COVID-19 - Medscape

    trials worldwide are pausing, changing, or halting the testing of the drug or the intervention," she told Medscape Medical News. "How the teams have adapted depends on the study," she added. "As you can imagine, things are changing on a daily basis."...

    https://mschristian.org/index.php/blog/trials-and-tribulations-neurology-research-during-covid-19-medscape
  • Despite Intense Public, Congressional Scrutiny, Pharma Still Hikes Prices For Hundreds Of Drugs In 2020 - Kaiser Health News

    at pharmacies. (Karlin-Smith, 1/2) This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. Original link Read More

    https://mschristian.org/index.php/articles/2-uncategorised/9686-despite-intense-public-congressional-scrutiny-pharma-still-hikes-prices-for-hundreds-of-drugs-in-2020-kaiser-health-news
  • The IDA Is Championing a Symbol for Invisible Disabilities - Multiple Sclerosis News Today

    other day I read about a woman who tripped, hit her head, and — you guessed it — was accused of being intoxicated. Fellow MS News Today columnist Teresa Wright-Johnson wrote about the problem of invisibility a year ago. I’m sure everyone reading this...

    https://mschristian.org/index.php/blog/the-ida-is-championing-a-symbol-for-invisible-disabilities-multiple-sclerosis-news-today
  • Delving into the psyche of war photographers - Canadian Jewish News

    “The most powerful weapon in the world is a photograph,” according to Associated Press photographer Eddie Adams, who took the incredibly-timed picture in 1968 of a South Vietnamese general shooting a suspected Viet Cong guerrilla in the head on the...

    https://mschristian.org/index.php/articles/2-uncategorised/8955-delving-into-the-psyche-of-war-photographers-canadian-jewish-news
  • Trending News Today: FDA Accepts NDA for Topical Rosacea Treatment - Pharmacy Times

    Officials with the FDA have accepted the New Drug Application for FMX103 (minocycline topical foam 1.5%, Foamix Pharmaceuticals), a topical foam for the treatment of moderate-to-severe papulopustular rosacea in adults,MD Magazinereported. According to...

    https://mschristian.org/index.php/articles/2-uncategorised/8954-trending-news-today-fda-accepts-nda-for-topical-rosacea-treatment-pharmacy-times
  • MS Progression Stopped by Targeting T Helper Cells with CXCR6 Receptor in Mouse Model - Multiple Sclerosis News Today

    Targeting the chemokine receptor CXCR6, a protein at the surface of a certain group of T helper cells, prevented the development of multiple sclerosis (MS) in a mouse model of the disease, a study reports. Its findings suggest that antibodies targeting...

    https://mschristian.org/index.php/articles/2-uncategorised/8854-ms-progression-stopped-by-targeting-t-helper-cells-with-cxcr6-receptor-in-mouse-model-multiple-sclerosis-news-today
  • Man behind viral ‘blinking guy’ GIF backs multiple sclerosis fundraiser - WTKR News 3

    SAN FRANCISCO (KPIX) — For anyone who has ever tried to craft the perfect text with just the right GIF to convey a feeling of confusion, he is right there for the using. Now, he has a request for the world at large. ** Embargo San Francisco-Oakland-San...

    https://mschristian.org/index.php/articles/2-uncategorised/8692-man-behind-viral-blinking-guy-gif-backs-multiple-sclerosis-fundraiser-wtkr-news-3
  • #ECTRIMS2019 - Longer DMT Use and Female Sex Seen to Protect Against SPMS Conversion - Multiple Sclerosis News Today

    Women with multiple sclerosis (MS), and people who stay in a relapsing stage or use disease-modifying therapies (DMTs) for longer periods are less likely to transition to secondary progressive multiple sclerosis (SPMS) than others, according to a study...

    https://mschristian.org/index.php/articles/2-uncategorised/8605-ectrims2019-longer-dmt-use-and-female-sex-seen-to-protect-against-spms-conversion-multiple-sclerosis-news-today
  • #ECTRIMS2019 - Transplanting MSCs Safe, Helps Stop Progressive MS - Multiple Sclerosis News Today

    Transplanting mesenchymal stem cells (MSCs) is safe and can delay disease progression in people with active, progressive multiple sclerosis (MS), according to results from a single-center clinical trial conducted in Israel. Six months after the...

    https://mschristian.org/index.php/articles/2-uncategorised/8603-ectrims2019-transplanting-mscs-safe-helps-stop-progressive-ms-multiple-sclerosis-news-today

Results 1 - 20 of 248